Skip to content
10-Q

Quarterly Report

Zymergen Inc.

0001645842-21-000018

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 30, 2021 102.39M sh
Long Term Debt Q2 2021 · Jun 30, 2021 $79.91M
Long Term Debt Q2 2021 · Dec 31, 2020 $0
Short Term Debt Q2 2021 · Jun 30, 2021 $0
Short Term Debt Q2 2021 · Dec 31, 2020 $79.33M
Current Liabilities Q2 2021 · Jun 30, 2021 $51.78M
Current Liabilities Q2 2021 · Dec 31, 2020 $121.46M
Total Liabilities Q2 2021 · Jun 30, 2021 $156.1M
Total Liabilities Q2 2021 · Dec 31, 2020 $147.86M
Current Assets Q2 2021 · Jun 30, 2021 $606.15M
Current Assets Q2 2021 · Dec 31, 2020 $228.57M
Total Assets Q2 2021 · Jun 30, 2021 $725.45M
Total Assets Q2 2021 · Dec 31, 2020 $304.92M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $21.83M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $42.96M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $18.1M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $42.67M
Revenue Q2 2021 · Jun 30, 2021 $4.88M
Revenue Q2 2021 · Jun 30, 2021 $7.49M
Revenue Q2 2021 · Jun 30, 2020 $771K
Revenue Q2 2021 · Jun 30, 2020 $2.68M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $210.21M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $24.58M
Shares Diluted Q2 2021 · Jun 30, 2020 12.29M sh
Shares Diluted Q2 2021 · Jun 30, 2020 11.81M sh
Capex Q2 2021 · Jun 30, 2020 $13.19M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$117.75M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$609.88M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$553.31M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$499.58M
Eps Diluted Q2 2021 · Jun 30, 2020 −$4.84
Eps Diluted Q2 2021 · Jun 30, 2020 −$10.57
Eps Basic Q2 2021 · Jun 30, 2020 −$4.84
Eps Basic Q2 2021 · Jun 30, 2020 −$10.57
Sga Expense Q2 2021 · Jun 30, 2020 $16.61M
Sga Expense Q2 2021 · Jun 30, 2020 $30.3M
Rd Expense Q2 2021 · Jun 30, 2020 $17.48M
Rd Expense Q2 2021 · Jun 30, 2020 $39.28M
Net Income Q2 2021 · Jun 30, 2020 −$59.44M
Net Income Q2 2021 · Jun 30, 2020 −$124.78M
Net Income Q2 2021 · Mar 31, 2020 −$65.34M
Operating Income Q2 2021 · Jun 30, 2020 −$55.56M
Operating Income Q2 2021 · Jun 30, 2020 −$118.21M